<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Accumulating evidence has suggested that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> have a hierarchical organization in which only the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells (<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>) have <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-initiating properties </plain></SENT>
<SENT sid="1" pm="."><plain>Several surface antigens have been employed to isolate <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> from various <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, although not from oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EA) </plain></SENT>
<SENT sid="2" pm="."><plain>We tested whether <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (BE) and EA might serve as a model for the <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> concept </plain></SENT>
<SENT sid="3" pm="."><plain>In vivo assays were performed by transplantation of serially diluted bulk EA cells into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>-<z:mp ids='MP_0002536'>SCID</z:mp> mice to establish the presence and frequency of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-initiating cells </plain></SENT>
<SENT sid="4" pm="."><plain>These were found to be present as ca </plain></SENT>
<SENT sid="5" pm="."><plain>1 in 64 000 cells </plain></SENT>
<SENT sid="6" pm="."><plain>The transplanted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> fully recapitulated the <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesions</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Subsequently, a panel of previously established <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> markers was employed for immunohistochemistry </plain></SENT>
<SENT sid="8" pm="."><plain>CD24, CD29 and CD44 showed <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> staining in EA </plain></SENT>
<SENT sid="9" pm="."><plain>Nuclear beta-catenin accumulation increased during progression from <z:mpath ids='MPATH_160'>metaplasia</z:mpath> to <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and was often observed in the basal compartment with CD24 and CD29 staining </plain></SENT>
<SENT sid="10" pm="."><plain>However, the overall staining patterns were not such to clearly point out specific candidate markers </plain></SENT>
<SENT sid="11" pm="."><plain>Accordingly, <z:hpo ids='HP_0000001'>all</z:hpo> markers were employed to sort the corresponding subpopulations of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells and transplant them at low multiplicities in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>-<z:mp ids='MP_0002536'>SCID</z:mp> mice </plain></SENT>
<SENT sid="12" pm="."><plain>No increased <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-initiating capacity of sorted EA cells was observed upon transplantation </plain></SENT>
<SENT sid="13" pm="."><plain>These results indicate that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-initiating cells are present in EA, thus reflecting a hierarchical organization </plain></SENT>
<SENT sid="14" pm="."><plain>However, antibodies directed against novel surface antigens are needed to detect subpopulations enriched for <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> in EA by transplantation assays </plain></SENT>
</text></document>